Stay updated with breaking news from Michael Trauner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Interim results from INTEGRIS-PSC to be featured in an oral presentation on Monday, November 13SOUTH SAN FRANCISCO, Calif., Oct. 19, 2023 -- Pliant Therapeutics, Inc. , a clinical-stage...
Non-alcoholic fatty liver disease and alcohol-related liver disease have different treatments and prognoses but can't be reliably determined by established diagnostic means. In a study, a new method has been used to determine alcohol consumption in fatty liver disease.
It is important to know whether patients have non-alcoholic fatty liver disease (NAFLD) or alcohol-related liver disease (ALD), as this distinction plays a key role in treatment and prognosis but cannot be reliably determined by established diagnostic means.